Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending March 23, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending March 23, 2025

by Jonathan Hodson-Walker | Mar 27, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Latigo Bio: The company raised $150 million of Series B venture funding in a deal led by Blue Owl Capital on March 17, 2025, putting the company’s pre-money valuation at $380...
Healthcare Private Placement and M&A Transactions Review Week Ending March 16, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending March 16, 2025

by Jonathan Hodson-Walker | Mar 19, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions BVI Medical: The company received $1 billion of development capital from TPG and other undisclosed investors on March 10, 2025. The company is a manufacturer of surgical devices...
Healthcare Private Placement and M&A Transactions Review Week Ending March 9, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending March 9, 2025

by Jonathan Hodson-Walker | Mar 12, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Callio Therapeutics: The company raised $187 million of Series A venture funding in a deal led by Frazier Healthcare Partners on March 3, 2025. Novo Holdings, Norwest Holdings, SEEDS...
Healthcare Private Placement and M&A Transactions Review Week Ending March 2, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending March 2, 2025

by Jonathan Hodson-Walker | Mar 6, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Eikon Therapeutics: The company raised $350.7 million of Series D venture funding from Foresite Capital, Lux Capital and The Column Group on February 26, 2025, putting the...
Healthcare Private Placement and M&A Transactions Review Week Ending Feb 23, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending Feb 23, 2025

by Jonathan Hodson-Walker | Feb 26, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Abridge: The company raised $250 million of Series D venture funding in a deal led by IVP and Elad Gil on February 19, 2005, putting the company’s pre-money valuation at $2.5...
Healthcare Private Placement and M&A Transactions Review Week Ending Feb 16, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending Feb 16, 2025

by Jonathan Hodson-Walker | Feb 20, 2025 | Healthcare

Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Abcuro: The company raised $200 million of Series C venture funding in a deal led by New Enterprise Associates on February 12, 2025, putting the company’s pre-money valuation...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 4, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending April 27, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending April 27, 2025

Categories

Archives